These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35579560)

  • 21. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression.
    Zhang Y; Yao YM; Huang LF; Dong N; Yu Y; Sheng ZY
    J Interferon Cytokine Res; 2011 Feb; 31(2):249-57. PubMed ID: 21087077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered regulatory T cells coexpressing MHC class II:peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis.
    Qian Z; Latham KA; Whittington KB; Miller DC; Brand DD; Rosloniec EF
    J Immunol; 2013 Jun; 190(11):5382-91. PubMed ID: 23630354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE.
    Wang N; Liang S; Jin J; Fang L; Ma Q; Wang X; Song Y; Chen L
    Immunol Res; 2019 Dec; 67(6):486-496. PubMed ID: 31919790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-34 deficiency impairs FOXP3
    Freuchet A; Salama A; Bézie S; Tesson L; Rémy S; Humeau R; Règue H; Sérazin C; Flippe L; Peterson P; Vimond N; Usal C; Ménoret S; Heslan JM; Duteille F; Blanchard F; Giral M; Colonna M; Anegon I; Guillonneau C
    Clin Transl Med; 2022 Aug; 12(8):e988. PubMed ID: 36030499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling.
    Bharat A; Fields RC; Trulock EP; Patterson GA; Mohanakumar T
    J Immunol; 2006 Oct; 177(8):5631-8. PubMed ID: 17015751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
    Chen X; Du Y; Huang Z
    Immunol Lett; 2012; 148(1):83-9. PubMed ID: 23000301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting Edge: Low-Affinity TCRs Support Regulatory T Cell Function in Autoimmunity.
    Sprouse ML; Shevchenko I; Scavuzzo MA; Joseph F; Lee T; Blum S; Borowiak M; Bettini ML; Bettini M
    J Immunol; 2018 Feb; 200(3):909-914. PubMed ID: 29282307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
    Müller M; Herrath J; Malmström V
    Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-β-dependent induction of CD4⁺CD25⁺Foxp3⁺ Tregs by liver sinusoidal endothelial cells.
    Carambia A; Freund B; Schwinge D; Heine M; Laschtowitz A; Huber S; Wraith DC; Korn T; Schramm C; Lohse AW; Heeren J; Herkel J
    J Hepatol; 2014 Sep; 61(3):594-9. PubMed ID: 24798620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of experimental autoimmune encephalomyelitis with engineered bi-specific Foxp3+ regulatory CD4+ T cells.
    Malviya M; Saoudi A; Bauer J; Fillatreau S; Liblau R
    J Autoimmun; 2020 Mar; 108():102401. PubMed ID: 31948790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4(+)Foxp3(+) T and IL-17(+)CD4(+) Th17 cells.
    Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Eo SK
    J Neuroinflammation; 2016 Jul; 13(1):223. PubMed ID: 27439902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinoembryonic antigen-related cell adhesion molecule 1 controls IL-2-dependent regulatory T-cell induction in immune-mediated hepatitis in mice.
    Horst AK; Wegscheid C; Schaefers C; Schiller B; Neumann K; Lunemann S; Langeneckert AE; Oldhafer KJ; Weiler-Normann C; Lang KS; Singer BB; Altfeld M; Diehl L; Tiegs G
    Hepatology; 2018 Jul; 68(1):200-214. PubMed ID: 29377208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoregulatory pathways controlling progression of autoimmunity in NOD mice.
    You S; Alyanakian MA; Segovia B; Damotte D; Bluestone J; Bach JF; Chatenoud L
    Ann N Y Acad Sci; 2008 Dec; 1150():300-10. PubMed ID: 19120317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp
    Ferreira RC; Castro Dopico X; Oliveira JJ; Rainbow DB; Yang JH; Trzupek D; Todd SA; McNeill M; Steri M; Orrù V; Fiorillo E; Crouch DJM; Pekalski ML; Cucca F; Tree TI; Vyse TJ; Wicker LS; Todd JA
    Front Immunol; 2019; 10():2606. PubMed ID: 31781109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity.
    Ferreira RC; Simons HZ; Thompson WS; Rainbow DB; Yang X; Cutler AJ; Oliveira J; Castro Dopico X; Smyth DJ; Savinykh N; Mashar M; Vyse TJ; Dunger DB; Baxendale H; Chandra A; Wallace C; Todd JA; Wicker LS; Pekalski ML
    J Autoimmun; 2017 Nov; 84():75-86. PubMed ID: 28747257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.
    Shuai X; Wei-min L; Tong YL; Dong N; Sheng ZY; Yao YM
    Sci Rep; 2015 Sep; 5():14478. PubMed ID: 26411375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors.
    Skapenko A; Kalden JR; Lipsky PE; Schulze-Koops H
    J Immunol; 2005 Nov; 175(9):6107-16. PubMed ID: 16237107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells.
    Yan F; Cai L; Hui Y; Chen S; Meng H; Huang Z
    Cell Biol Int; 2014 Jul; 38(7):835-48. PubMed ID: 24604878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.
    Arandi N; Mirshafiey A; Jeddi-Tehrani M; Shaghaghi M; Sadeghi B; Abolhassani H; Sharifian RA; Rahiminejad MS; Aghamohammadi A
    Iran J Allergy Asthma Immunol; 2014 Apr; 13(2):85-92. PubMed ID: 24338252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-37 Enhances the Suppressive Activity of Naturally Occurring CD4
    Wang DW; Dong N; Wu Y; Zhu XM; Wang CT; Yao YM
    Sci Rep; 2016 Dec; 6():38955. PubMed ID: 27941849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.